Qubit Pharmaceuticals Competitors and Similar CompaniesClear all

Qubit Pharmaceuticals's competitors and similar companies include Evaxion Biotech and ImmunoGen.

	Qubit Pharmaceuticals Qubit Pharmaceuticals is a company that provides physics-driven drug discovery solutions.	Evaxion Biotech Evaxion Biotech A/S is a company focused on the development of vaccines against cancer and infectious diseases.	ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
Founding Date	Founding Date 2020	Founding Date 2008	Founding Date 1981
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare artificial intelligence biotech drug development oncology quantum computing simulation	Tags Healthcare artificial intelligence biotech drug development oncology platform	Tags Healthcare biotech drug development oncology
Locations	Locations Paris, FR HQ	Locations København, DK HQ	Locations Waltham, US HQ
Employees	Employees 701% decrease	Employees 558% decrease	Employees 277161% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 16.2 m	Valuation ($) 8.7 b
Financial
Revenue (est.)	Revenue (est.) €76.7k (FY, 2023)	Revenue (est.) $7.5m (FY, 2025)	Revenue (est.) $108.8m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $176k (FY, 2022)
Gross profit	Gross profit N/A	Gross profit $7.5m (FY, 2025)	Gross profit $108.6m (FY, 2022)
Net income	Net income (€133.4k) (FY, 2023)	Net income ($7.7m) (FY, 2025)	Net income ($222.9m) (FY, 2022)
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications 34 (Feb, 2021)	Patent Applications 600 (FY, 2020)
Patents Issued	Patents Issued N/A	Patents Issued 12 (Feb, 2021)	Patents Issued 1.4 k (FY, 2020)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 17m	Total funding raised $ 56m